Body Pharm Tirzepatide 60mg

Overview

Body Pharm Tirzepatide 60 mg is a sealed, pre-filled multi-dose research pen containing 60 mg of tirzepatide (LY3298176) in solution. Tirzepatide is a synthetic 39-amino-acid peptide based on the native GIP sequence, modified with a C20 fatty-diacid moiety, that acts as a dual agonist at the GIP and GLP-1 receptors.

The pen is a laboratory research material. It is supplied strictly for laboratory research and is not for human or veterinary use. It is not a medicine, food, dietary supplement or cosmetic, and no medical, therapeutic or performance claims are made or implied. No dosing information is provided.

Research background

In the characterisation work published by Coskun and colleagues (2018), tirzepatide bound GIPR with affinity comparable to native GIP and GLP-1R with lower affinity than native GLP-1, giving a GIP-biased dual-agonist profile; at GLP-1R it showed biased signalling favouring cAMP generation over β-arrestin recruitment [1]. In the laboratory it is used as a dual-agonist reference compound in receptor-binding and signalling assays, and in preclinical metabolic models designed to isolate the contribution of GIP-receptor activation on top of GLP-1-receptor activation [1][2].

Tirzepatide sits between the GLP-1-selective comparator (semaglutide) and the tri-agonist retatrutide in receptor coverage; the three are compared in our receptor pharmacology guide and the Tirzepatide monograph.

Specification

• Compound: Tirzepatide (LY3298176)
• Declared quantity: 60 mg per pen
• CAS: 2023788-19-2
• Molecular formula: C225H348N48O68
• Format: Solution, pre-filled multi-dose research pen
• Also available: Tirzepatide 30 mg

Quality documentation

Every batch is HPLC-tested for purity and identity. The batch-specific Certificate of Analysis is published on this page and on our Certificates of Analysis page, and the batch number is printed on the pen label.

Storage and handling

Store refrigerated at 2–8 °C. Protect from light. Do not freeze. Handle only with appropriate personal protective equipment in a laboratory setting and dispose of the pen as laboratory sharps waste. Keep out of reach of children and animals.

Supply, dispatch and returns

Dispatched from the UK by tracked Royal Mail in plain outer packaging; most UK orders arrive within 1–3 working days. Shipping is free on UK pen orders. Unused, unopened pens with the seal intact may be returned within 14 days of delivery; opened pens cannot be returned. See shipping and returns.

Frequently Asked Questions

Is Tirzepatide 60mg for human use?

No. It is supplied strictly for laboratory research and is not for human or veterinary use. No dosing or administration information is provided.

What receptors does tirzepatide act on?

Tirzepatide is a dual agonist at the GIP and GLP-1 receptors, with a GIP-biased profile in reported binding assays.

How is purity verified?

Each batch is HPLC-tested for purity and identity; the Certificate of Analysis for that batch is published on this page.

How should the pen be stored?

Refrigerated at 2–8 °C, protected from light, never frozen.

References

1. Coskun T, et al. LY3298176, a novel dual GIP and GLP-1 receptor agonist: from discovery to clinical proof of concept. Mol Metab. 2018. pubmed.ncbi.nlm.nih.gov/30473097
2. PubChem compound summary: Tirzepatide. pubchem.ncbi.nlm.nih.gov/compound/Tirzepatide